OTC:CERO | Cash Flow Statement | CERO THERAPEUTICS HOLDINGS, INC.

Complete source-backed cash-flow history.

Available history
2021-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.03M
2026-03-31-$5.89M$2.8M$127,144.00
2025-12-31-$4.54M$0.00
2025-09-30-$4.86M
2025-06-30-$5.42M
2025-03-31-$5.11M$127,144.00
2024-09-30-$4.23M
2024-06-30-$2.45M
2023-12-31-$5.04M-$186,609.00-$13.82M$27.84M-$27.68M
2023-09-30-$334,028.00
2023-06-30-$2.09M
2023-03-31-$2.44M-$197,777.00-$100,000.00
2022-12-31-$262,675.00-$373,100.00$180.71M
2022-09-30$84,505.00
2022-06-30-$111,569.00
2022-03-31-$377,997.00-$308,091.00$0.00
2021-09-30-$1,000.00$0.00$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$19.92M-$16.1M$127,144.00
2023-12-31-$7.29M-$1.52M-$7.94M$33.48M-$32.58M
2022-12-31-$667,736.00-$1.09M$180.84M$139.35M-$138.7M